VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 186 filers reported holding VIKING THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50 | -31.5% | 4,523 | 0.0% | 0.00% | – |
| Q2 2023 | $73 | -5.2% | 4,523 | -2.0% | 0.00% | -100.0% |
| Q1 2023 | $77 | +92.5% | 4,617 | +9.3% | 0.00% | – |
| Q4 2022 | $40 | -99.7% | 4,226 | -1.4% | 0.00% | – |
| Q3 2022 | $12,000 | -14.3% | 4,284 | -9.1% | 0.00% | – |
| Q2 2022 | $14,000 | -22.2% | 4,711 | -21.6% | 0.00% | – |
| Q1 2022 | $18,000 | -5.3% | 6,009 | +47.7% | 0.00% | – |
| Q4 2021 | $19,000 | -20.8% | 4,069 | +1.7% | 0.00% | – |
| Q2 2021 | $24,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2021 | $24,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q4 2020 | $24,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q3 2020 | $24,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q2 2020 | $24,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2020 | $24,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q4 2019 | $24,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q3 2019 | $24,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q2 2019 | $24,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2019 | $24,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |